Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study.
Minicozzi, Pamela;
Kaleci, Shaniko;
Maffei, Stefania;
Allemani, Claudia;
Giacomin, Adriano;
Caldarella, Adele;
Iachetta, Francesco;
Fusco, Mario;
Tumino, Rosario;
Vicentini, Massimo;
+4 more...Falcini, Fabio;
Cesaraccio, Rosaria;
Ponz de Leon, Maurizio;
Sant, Milena;
(2013)
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study.
European journal of public health, 24 (1).
pp. 98-100.
ISSN 1101-1262
DOI: https://doi.org/10.1093/eurpub/ckt056
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
We analysed presentation, treatment and survival in a representative population-based sample of 3753 Italian colorectal cancer cases, diagnosed 2003-05: 70% were >65 years, 44% stage I-II, 27% stage IV and 92% received surgery. Chemotherapy was given to 58% of stage III colon cases, radiotherapy to 25% of rectal cases. Four percent of surgical cases underwent endoscopic polypectomy, and in 57% ≥11 lymph nodes were examined. Five-year relative survival was good (60%), independent of sex and site. Adherence to treatment guidelines was satisfactory, but wider use of faecal blood testing and colonoscopy will anticipate stage at diagnosis and likely improve survival.
